Absence of significant clinical benefit for a systematic routine creatine phosphokinase measurement in asymptomatic patients treated with anti-programmed death protein (ligand) 1 immune checkpoint inhibitor to screen cardiac or neuromuscular immune-related toxicities
Titel:
Absence of significant clinical benefit for a systematic routine creatine phosphokinase measurement in asymptomatic patients treated with anti-programmed death protein (ligand) 1 immune checkpoint inhibitor to screen cardiac or neuromuscular immune-related toxicities
Auteur:
Hajem, Samia Ederhy, Stéphane Champiat, Stéphane Troalen, Frédéric Nolin-Lapalme, Alexis Berhoune, Malik Cauquil, Cécile Martin-Romano, Patricia Baldini, Capucine Laparra, Ariane Vuagnat, Perrine Hollebecque, Antoine Mateus, Christine Besse, Benjamin Naltet, Charles Robert, Caroline Marabelle, Aurélien Massard, Christophe Lambotte, Olivier Michot, Jean-Marie